- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- March 2025
- 175 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- December 2024
- 175 Pages
Global
From €4551EUR$5,000USD£3,865GBP
- Report
- July 2024
- 177 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- March 2025
- 180 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- July 2024
- 105 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- November 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- September 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- February 2025
- 143 Pages
Global
From €3595EUR$3,950USD£3,054GBP
- Report
- January 2025
- 127 Pages
Global
From €2685EUR$2,950USD£2,281GBP
- Report
- July 2024
- 157 Pages
Global
From €3288EUR$3,613USD£2,793GBP
€3868EUR$4,250USD£3,285GBP
- Report
- February 2025
- 128 Pages
Global
From €3973EUR$4,365USD£3,374GBP
€4414EUR$4,850USD£3,749GBP
- Report
- May 2024
- 130 Pages
United States
From €5416EUR$5,950USD£4,600GBP

Radiopharmaceuticals are a type of biopharmaceutical used in medical imaging and therapy. They are typically composed of a radioactive isotope, such as technetium-99m, bound to a biologically active molecule, such as a peptide or antibody. Radiopharmaceuticals are used to diagnose and treat a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. They are administered intravenously, orally, or by inhalation, depending on the type of radiopharmaceutical and the desired therapeutic effect.
The radiopharmaceutical market is a rapidly growing segment of the biopharmaceutical industry. It is driven by advances in medical imaging technology, the development of new radiopharmaceuticals, and the increasing prevalence of diseases that can be treated with radiopharmaceuticals.
Some of the major companies in the radiopharmaceutical market include GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Imaging, and Lantheus Medical Imaging. Show Less Read more